Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-22

Clinical Trial Update: Safety and Efficacy of Wendan Decoction in Acute Moderated to Severe Brain Injury [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 results evaluating the safety and efficacy of Wendan Decoction for acute brain injury (moderate to severe) are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Wendan Decoction

Snippet

Sponsor: Taichung Tzu Chi Hospital | Conditions: Acute Brain Injury | Phase 2, Phase 3 | Status: COMPLETED